Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy.

MLA

Aldika Akbar, Muhammad Ilham, et al. “Serum Heme Oxygenase 1 (HO-1), Soluble FMS like Tyrosine Kinase (SFlt-1) Level, and Neonatal Outcome in Early Onset, Late Onset Preeclampsia, and Normal Pregnancy.” Hypertension in Pregnancy, vol. 37, no. 4, Nov. 2018, pp. 175–81. EBSCOhost, https://doi.org/10.1080/10641955.2018.1494187.

APA

Aldika Akbar, M. I., Herdiyantini, M., Aryananda, R. A., CIninta, N., Wardhana, M. P., Gumilar, K. E., Wicaksono, B., Ernawati, Sulistyono, A., Aditiawarman, Joewono, H. T., Nadir Abdullah, Dekker, G., Dachlan, E. G., & Dikman Angsar, M. (2018). Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy. Hypertension in Pregnancy, 37(4), 175–181. https://doi.org/10.1080/10641955.2018.1494187

Chicago

Aldika Akbar, Muhammad Ilham, Mita Herdiyantini, Rozi Aditya Aryananda, Nareswari CIninta, Manggala Pasca Wardhana, Khanisyah Erza Gumilar, Budi Wicaksono, et al. 2018. “Serum Heme Oxygenase 1 (HO-1), Soluble FMS like Tyrosine Kinase (SFlt-1) Level, and Neonatal Outcome in Early Onset, Late Onset Preeclampsia, and Normal Pregnancy.” Hypertension in Pregnancy 37 (4): 175–81. doi:10.1080/10641955.2018.1494187.